Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies.

Tuzmen C, Cairns TM, Atanasiu D, Lou H, Saw WT, Hall BL, Cohen JB, Cohen GH, Glorioso JC
Mol Ther Methods Clin Dev. 2020 Jan 13;16:145-154. doi: 10.1016/j.omtm.2019.12.013. eCollection 2020 Mar 13. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.